Novo Nordisk Investigational Site

Bolton BL4 0JR

0 studies enrolling now · 3 studies all time

What they study most

Diabetes, Diabetes Mellitus, Type 2, Hepatobiliary Disorders, Non-alcoholic Steatohepatitis

Studies at this site

• Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. — Completed
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes — Completed
• Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes — Completed